FTRE
FORTE SOFTWARE INC (FTRE)
Healthcare • NASDAQ • $15.43-0.90%
- Symbol
- FTRE
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $15.43
- Daily Change
- -0.90%
- Market Cap
- $1.46B
- Trailing P/E
- N/A
- Forward P/E
- 14.57
- 52W High
- $18.67
- 52W Low
- $3.97
- Analyst Target
- $16.03
- Dividend Yield
- N/A
- Beta
- 1.91
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. T…
Company websiteResearch FTRE on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.